Ocupharm Research Group
Research Group
The research group “Pharmacological Biochemistry of the Eye (Ocupharm-92077)” is composed of professors, researchers, and doctoral students from various Departments and Teaching Units at the Faculty of Optics and Optometry at the Complutense University of Madrid.
Since 1997, when it was founded by Professor Jesús Pintor Just, it has operated in the field of pharmacological biochemistry of the eye, with its main areas of interest being:
- The study of purinergic signalling in the eye
- The study of the melatoninergic system in the eye
- Research on the ocular surface: tear film, dry eye syndrome, conjunctival surface and corneal healing, infections
- Research on ocular hypertension and glaucoma
- Research in Advanced Contactology: drug release, irregular cornea
- Research in myopia control
Since its inception, and continuing to the present day, this activity has been supported by numerous national and international research projects, funded by both public bodies and private companies.
Moreover, the group is part of organisations, national networks, and associations such as OftaRed or Retibrain, which have enabled us to establish productive partnerships and collaborations with other national and European research centres. Thanks to all of this, the group also has significant training capabilities, which is why we always have a high number of master’s students and PhD candidates in our team.
Ocupharm Research Group
It is a multidisciplinary research group at the Complutense University of Madrid (“Pharmacological Biochemistry of the Eye – Ocupharm-92077”).
